Emergency treatment for ζ chain–associated protein of 70 kDa (ZAP70) deficiency - 30/03/13
Doi : 10.1016/j.jaci.2012.09.020
Vy Hong-Diep Kim, MD, FRCPC a, d, e, Luis Murguia, MD a, d, e, Tal Schechter, MD b, d, e, Eyal Grunebaum, MD a, d, e, Chaim M. Roifman, MD, FRCPC a, c, d, e 
a Division of Immunology and Allergy, Toronto, Ontario, Canada
b Hematology Oncology, Toronto, Ontario, Canada
c Canadian Centre for Primary Immunodeficiency, the Jeffrey Modell Research Laboratory for the Diagnosis of Primary Immunodeficiency, Toronto, Ontario, Canada
d Hospital for Sick Children, Toronto, Ontario, Canada
e University of Toronto, Toronto, Ontario, Canada
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2012
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 131 - N° 4
P. 1233-1235 - avril 2013 Retour au numéro
Article précédent
- Persistence of natural killer cells with expansion of a hypofunctional CD56−CD16+KIR+NKG2C+ subset in a patient with atypical Janus kinase 3–deficient severe combined immunodeficiency
- Laure Farnault, Hervé Chambost, Gérard Michel, Isabelle Thuret, Geneviève de Saint Basile, Alain Fischer, Capucine Picard, Christophe Picard, Florence Orlanducci, Catherine Farnarier, Alessandro Moretta, Daniel Olive
- Induction of severe systemic lupus erythematosus by TNF blockade and response to anti–IL-6 strategy
- Sabine Adler, Mirjam Kolev, Pierre-Alain Varisco, Manuela Tham, Michael von Gunten, Christoph Tappeiner, Peter M. Villiger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?